ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 308847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 308847; 2) Community: the network communities that were significantly associated with the response to NSC 308847; 3) Molecule: the relationships between components within communities and NSC 308847; 4) MDR: the compounds that were significantly associated with the NSC 308847.

NSC Compound Enrichment Correlation
NSC 681638 Camptothecin Derivative 0.0386895225700407 0.29516293
NSC 693167 Null 0.0386895225700407 0.34453224
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0386895225700407 0.33059903
NSC 724706 Null 0.0386895225700407 0.28471896
NSC 727350 benzoanthracenone 0.0386895225700407 0.26584581
NSC 733882 6-(3-Azidopropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.0386895225700407 0.36457574
NSC 740644 6-(3-Bromopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0386895225700407 0.30634043
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0386895225700407 0.30725067
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0386895225700407 0.51403674
NSC 752879 3-(3-chloro-5-methoxyphenyl)-N-(2-(4-methylpiperazin-1-yl)ethyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.038689522570041 -0.31913387
Total:60  Current:39    [First] [Prev] [Next] [Last]